The need for PGY2-trained clinical pharmacy specialists

Pharmacotherapy

Volumn 34, Issue 6, 2014, Pages

  Ragucci, Kelly R ^a   O'Bryant, Cindy L ^a   Campbell, Kristin Bova ^a   Buck, Marcia L ^a   Dager, William E ^a   Donovan, Jennifer L ^a   Emerson, Kayleigh ^a   Gubbins, Paul O ^a   Haight, Robert J ^a   Jackevicius, Cynthia ^a   Murphy, John E ^a   Prohaska, Emily ^a  

^a American College of Clinical Pharmacy   (United States)

Author keywords

clinical pharmacy; direct patient care; PGY2 pharmacy residency; pharmacy education; pharmacy practice model initiative; specialists

Indexed keywords

CLINICAL PHARMACY; DRUG SAFETY; ECONOMIC ASPECT; EMERGENCY CARE; FUNDING; HEALTH CARE NEED; HEALTH CARE POLICY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MEDICAL SPECIALIST; PHARMACIST ATTITUDE; PHARMACY STUDENT; POSTGRADUATE EDUCATION; PRIMARY MEDICAL CARE; REVIEW; EDUCATION; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; ORGANIZATION AND MANAGEMENT; PHARMACIST; PRIMARY HEALTH CARE; PROCEDURES; SPECIALIZATION; STANDARDS; SUPPLY AND DISTRIBUTION; TRENDS; UNITED STATES;

DELIVERY OF HEALTH CARE, INTEGRATED; EDUCATION, PHARMACY, GRADUATE; HUMANS; PHARMACISTS; PHARMACY RESIDENCIES; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; SOCIETIES, PHARMACEUTICAL; SPECIALIZATION; STUDENTS, PHARMACY; UNITED STATES;

EID: 84902290031     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1430     Document Type: Review

References (63)

1. ASHP.org [homepage of the Internet]. Available from http://www.ashp.org. Accessed October 3, 2012.
2. Letendre DE, Brooks PJ, Degenhart ML,. The evolution of pharmacy residency training programs and corresponding standards of accreditation. Pharm Pract Manag Q 1995; 15: 30-43.
3. Lee M, Bennett M, Chase P, et al. Final report and recommendations of the 2002 AACP task force on the role of colleges and schools in residency training. Am J Pharm Educ 2004; 68: 1-19, Article s2.
4. Murphy JE, Nappi JM, Bosso JA, et al. American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy 2006; 26: 722-33.
5. Alloway RR, Dupuis R, Gabardi S, et al. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant 2011; 11: 1576-83.
6. Anonymous. The United Network of Organ Sharing bylaws; attachment 1 to appendix B of the UNOS bylaws: designated transplant program criteria. UNOS-appendix B; attachment I-XIII-1-91.
7. Department of Health and Human Services. Centers for Medicare & Medicaid Services 42 CFR Parts 405, 482, 488, and 498 Medicare Program. Hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplant; final rule. Fed Reg 2007; 72: 15197-9.
8. Joint Commission. Sentinel Event Alert, Issue 39: Preventing pediatric medication errors. April 11, 2008. Available from http://www.jointcommission. org/assets/1/18/SEA-39.PDF. Accessed October 3, 2012.
9. Committee on Drugs and Committee on Hospital Care, American Academy of Pediatrics. Prevention of medication errors in the pediatric inpatient setting. Pediatrics 2003; 112: 431-6.
10. Rosenberg DI, Moss M, Section on Critical Care and Committee on Hospital Care, American Academy of Pediatrics. Guidelines and levels of care for pediatric intensive care units. Pediatrics 2004; 114: 1114-25.
11. Stark AR, American Academy of Pediatrics Committee on Fetus and Newborn. Levels of neonatal care. Pediatrics 2004; 114: 1341-7.
12. Section on Hematology/Oncology, American Academy of Pediatrics. Guidelines for pediatric cancer centers. Pediatrics 2004; 113: 1833-5.
13. Tuffiana HW, Abdelhadi O, Omar SA,. Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. Int J Clin Pharm 2012; 34: 27-31.
14. So TY, Layton JB, Bozik K, et al. Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Renal Fail 2011; 33: 19-25.
15. Society of Critical Care Medicine and American College of Clinical Pharmacy. Position paper on critical care pharmacy services. Pharmacotherapy 2000; 20: 1400-6.
16. Brilli RJ, Spevetz A, Branson RD, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med 2001; 29: 2007-19.
17. Dager W, Bolesta S, Brophy G, et al. An opinion paper outlining recommendations for training, credentialing, documenting and justifying critical care pharmacy services. Pharmacotherapy 2011; 31: 135e-75e.
18. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
19. Ernst EJ, Klepser ME, Bosso JA, et al. Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy. Pharmacotherapy 2009; 29: 482-8.
20. American Society of Health-System Pharmacists and Society of Infectious Diseases Pharmacists. Required and elective educational outcomes, goals, objectives and instructional objectives for postgraduate year two (PGY2) pharmacy residency in infectious diseases, 2007. Available from http://www.ashp.org/menu/Accreditation/ResidencyAccreditation.aspx. Accessed September 7, 2012.
21. Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 suppl): e44S-e88s.
22. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41: 263-306.
23. Tesoro EP, Brophy GM,. Pharmacological management of seizures and status epilepticus in critically ill patients. J Pharm Pract 2010; 23: 441-54.
24. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30: 142-56.
25. ASHP Commission on Therapeutics. ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm 1999; 56: 347-79.
26. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003; 289: 2560-71.
27. Patanwala AE, Thomas MC, Casanova TJ, et al. Pharmacists' role in procedural sedation and analgesia in the emergency department. AJHP 2012; 69: 1336-42.
28. Defrates SR, Weant KA, Seamon JP, et al. Emergency pharmacist impact on health care-associated pneumonia empiric therapy. J Pharm Pract 2013; 26 (2): 125-30.
29. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
30. McKenny JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 1973; 48: 1104-11.
31. Mehos BM, Saseen JJ, MacLaughlin EJ,. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000; 20: 1384-9.
32. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 2008; 299: 2857-67.
33. Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension. Arch Intern Med 2009; 169: 1748-55.
34. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT,. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med 2008; 168: 687-94.
35. Wilt VM, Gums JG, Ahmed OI, Moore LM,. Outcome analysis of a pharmacy-managed anticoagulation service. Pharmacotherapy 1995; 15: 732-9.
36. Chiquette E, Amato MG, Bussey HI,. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998; 158: 1641-7.
37. Witt DM, Sadler MA, Shanahan RL, et al. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 2005; 127: 1515-22.
38. Al-Mazroui NR, Kamal MM, Ghabash NM, et al. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67: 547-57.
39. Clifford RM, Davis WA, Batty KT, David TME,. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005; 28: 771-6.
40. Ragucci KR, Fermo JD, Wessell AM, Chumney ECG,. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy 2005; 25: 1809-16.
41. Padiyara RS, D'Souza JJ, Rihani RS,. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group. J Manag Care Pharm 2011; 17: 456-62.
42. Aistrope DS, Attridge RT, Bickley AR, et al. Strategies for developing pharmacy residents as educators. Pharmacotherapy 2011; 31: 65e-70e.
43. Pedersen CA, Schneider PJ, Scheckelhoff DJ,. ASHP National Survey of Pharmacy Practice in hospital settings: dispensing and administration-2011. Am J Health Syst Pharm 2012; 69: 768-85.
44. The American Society of Health-System Pharmacists and the American Association of Colleges of Pharmacy. Capacity of hospitals to partner with academia to meet experiential education requirements for pharmacy students. Am J Pharm Educ 2008; 65: e53-71.
45. Knapp KK, Manolakis M, Webster AA, Olsen KM,. Projected growth in pharmacy education and research, 2010 to 2015. Am J Pharm Educ 2011; 75: 1-7, Article 108.
46. Beardsley R, Matzke GR, Rospond R, et al. Factors influencing the pharmacy faculty workforce. Am J Pharm Educ 2008; 72: 1-11, Article 34.
47. Johnson TJ, Teeters JL,. Pharmacy residency and the medical training model: is pharmacy at a tipping point? Am J Health Syst Pharm 2011; 68: 1542-9.
48. Knapp DA, Knapp DE,. Attributes of colleges and schools of pharmacy in the United States. Am J Pharm Educ 2009; 73: 96.
49. American Association of Colleges of Pharmacy. Academic pharmacy's vital statistics. Available from http://www.aacp.org/about/pages/vitalstats.aspx. Accessed October 3, 2012.
50. American Association of Colleges of Pharmacy. 2008 annual report. Available from http://www.aacp.org/news/reports/pages/default.aspx. Accessed October 3, 2012.
51. American Association of Colleges of Pharmacy. 2009 annual report. Available from http://www.aacp.org/news/reports/pages/default.aspx. Accessed October 3, 2012.
52. American Association of Colleges of Pharmacy. 2010 annual report. Available from http://www.aacp.org/news/reports/pages/default.aspx. Accessed October 3, 2012.
53. American Association of Colleges of Pharmacy. 2011 annual report. Available from http://www.aacp.org/news/reports/pages/default.aspx. Accessed October 3, 2012.
54. American Society of Health-System Pharmacists. Pharmacy Practice Model Initiative. Available from http://www.ashp.org/ppmi. Accessed September 30, 2012.
55. American Society of Health-System Pharmacists. Policy position 0701: requirement for residency. Available from http://www.ashp.org/DocLibrary/ BestPractices/policypositions2009.aspx. Accessed September 30, 2012.
56. ACCP Commentary. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification. Available from http://www.accp.com/docs/positions/commentaries/ACCP-Brd- Commntry-Qualifications.pdf. Accessed May 3, 2013.
57. Ashby DM,. Permission granted. Am J Health Syst Pharm 2011; 68: 1497-504.
58. Bush PW, Ashby DM, Gubaroy R, et al. Pharmacy practice model for academic medical centers. Am J Health Syst Pharm 2010; 67: 1856-61.
59. Hertig J,. New practitioners and the Pharmacy Practice Model Initiative: our opportunity to define the future. Am J Health Syst Pharm 2011; 68: 1074-6.
60. Bush PW,. Role of residency training in the development of practice models [editorial]. Am J Health Syst Pharm 2009; 66: 1623-4.
61. Shane R,. Critical requirements for health-system pharmacy practice models that achieve optimal use of medicines. Am J Health Syst Pharm 2011; 68: e65-75.
62. ASHP Resident Matching Program. Summary of programs and positions offered and filled by program type for the 2011 match. Available from http://www.natmatch.com/ashprmp/. Accessed October 10, 2012.
63. Murphy JE, Hawkey L,. Education, postgraduate training, board certification and experience requirements in advertisements for clinical faculty positions. Am J Pharm Educ 2010; 74: 1-5, Article 73.